BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31500997)

  • 1. A potent aminonaphthalimide platinum(IV) complex with effective antitumor activities in vitro and in vivo displaying dual DNA damage effects on tumor cells.
    Wang Q; Chen Y; Li G; Zhao Y; Liu Z; Zhang R; Liu M; Li D; Han J
    Bioorg Med Chem Lett; 2019 Oct; 29(20):126670. PubMed ID: 31500997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a new series of low toxic naphthalimide platinum(IV) antitumor complexes with dual DNA damage mechanism.
    Wang Q; Tan X; Liu Z; Li G; Zhang R; Wei J; Wang S; Li D; Wang B; Han J
    Eur J Pharm Sci; 2018 Nov; 124():127-136. PubMed ID: 30153524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance.
    Li Y; Yue K; Li L; Niu J; Liu H; Ma J; Xie S
    Bioorg Chem; 2020 Aug; 101():104011. PubMed ID: 32599363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naproxen platinum(iv) hybrids inhibiting cycloxygenases and matrix metalloproteinases and causing DNA damage: synthesis and biological evaluation as antitumor agents in vitro and in vivo.
    Chen Y; Wang Q; Li Z; Liu Z; Zhao Y; Zhang J; Liu M; Wang Z; Li D; Han J
    Dalton Trans; 2020 Apr; 49(16):5192-5204. PubMed ID: 32236281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of dihydro-2-quinolone platinum(iv) hybrids as antitumor agents displaying mitochondria injury and DNA damage mechanism.
    Liu Z; Li Z; Du T; Chen Y; Wang Q; Li G; Liu M; Zhang N; Li D; Han J
    Dalton Trans; 2021 Jan; 50(1):362-375. PubMed ID: 33319888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a series of 4-hydroxycoumarin platinum(IV) hybrids as antitumor agents: Synthesis, biological evaluation and action mechanism investigation.
    Li G; Zhang J; Liu Z; Wang Q; Chen Y; Liu M; Li D; Han J; Wang B
    J Inorg Biochem; 2019 May; 194():34-43. PubMed ID: 30826588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platinum(IV) complexes conjugated with phenstatin analogue as inhibitors of microtubule polymerization and reverser of multidrug resistance.
    Huang X; Huang R; Gou S; Wang Z; Liao Z; Wang H
    Bioorg Med Chem; 2017 Sep; 25(17):4686-4700. PubMed ID: 28728896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing Cytotoxicity of a Monofunctional Platinum Complex via a Dual-DNA-Damage Approach.
    Guo Y; He Y; Wu S; Zhang S; Song D; Zhu Z; Guo Z; Wang X
    Inorg Chem; 2019 Oct; 58(19):13150-13160. PubMed ID: 31539237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
    Huang X; Wang M; Wang C; Hu W; You Q; Yang Y; Yu C; Liao Z; Gou S; Wang H
    Bioorg Chem; 2019 Nov; 92():103236. PubMed ID: 31494328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fresh platinum complexes with promising antitumor activity.
    Wang X
    Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum(IV) complexes conjugated with chalcone analogs as dual targeting anticancer agents: In vitro and in vivo studies.
    Huang X; Liu Z; Wang M; Yin X; Wang Y; Dai L; Wang H
    Bioorg Chem; 2020 Dec; 105():104430. PubMed ID: 33171407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
    Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
    J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance.
    Li L; Huang X; Huang R; Gou S; Wang Z; Wang H
    Eur J Med Chem; 2018 Aug; 156():666-679. PubMed ID: 30031977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.
    Banerjee S; Kitchen JA; Bright SA; O'Brien JE; Williams DC; Kelly JM; Gunnlaugsson T
    Chem Commun (Camb); 2013 Oct; 49(76):8522-4. PubMed ID: 23942760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands.
    Navas F; Mendes F; Santos I; Navarro-Ranninger C; Cabrera S; Quiroga AG
    Inorg Chem; 2017 Jun; 56(11):6175-6183. PubMed ID: 28488859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhetinic Acid as a Hepatocyte Targeting Ligand-Functionalized Platinum(IV) Complexes for Hepatocellular Carcinoma Therapy and Overcoming Multidrug Resistance.
    Huang X; Li G; Li H; Zhong W; Jiang G; Cai J; Xiong Q; Wu C; Su K; Huang R; Xu S; Liu Z; Wang M; Wang H
    J Med Chem; 2024 May; 67(10):8020-8042. PubMed ID: 38727048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antitumor evaluation of new 1,8-naphthalimide derivatives targeting nuclear DNA.
    Liang GB; Wei JH; Jiang H; Huang RZ; Qin JT; Wang HL; Wang HS; Zhang Y
    Eur J Med Chem; 2021 Jan; 210():112951. PubMed ID: 33109400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.